主页
市场
图表与思路
Algo
新闻
Store
经纪商
下载
经济日历
交易信号
网页端
键入
/
进行搜索:@user,$symbol
查找
登录
创建账户
中文
English
Русский
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
VRDN
#3858
Viridian Therapeutics, Inc. Common Stock
29.380
0
+2.98%
版块:
基础:
利润货币:
日范围
年范围
日变化
+2.98%
每月变动
-12.59%
6个月变化
+30.87%
年变化
+30.87%
前一天收盘价
28.530
0
Open
29.380
0
Bid
Ask
Low
29.380
0
High
29.380
0
交易量
105
市场
股票
医疗保健
VRDN
Open full chart
Financials
Overview
声明
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
2025
TTM
Key stats
Total common shares outstanding
7.23 M
25.91 M
42.9 M
62.77 M
81.48 M
102.21 M
—
Valuation ratios
Enterprise value
—
646.14 M
1.36 B
1.61 B
1.75 B
3.31 B
8.18 B
Price to earnings ratio
—
-2.97
-7.04
-4.21
0.05
0.07
0.14
Price to sales ratio
—
79.53
516.08
3 185.62
19.03
—
—
Price to cash flow ratio
—
4.32
9.75
5.43
0.02
0.03
0.09
Price to book ratio
—
4.37
3.62
4.25
0.01
0.01
0.03
Enterprise value to EBITDA ratio
—
—
—
—
—
—
—
Profitability ratios
Return on assets %
-0.84
-0.39
-0.3
-0.48
-0.36
0.38
-0.23
Return on equity %
-0.92
-0.42
-0.33
-0.54
-0.4
0.47
-0.24
Return on invested capital %
-15.85 K
-14.4 K
-16.57 K
-30.31 K
-32.85 K
30.88 K
—
Gross margin %
100
100
100
100
100
100
400
Operating margin %
-10.51 K
-2 690.79
-7 579.23
-81.04 K
-99.02 K
512.91
-179.79 K
EBITDA margin %
—
—
—
—
—
—
—
Net margin %
-10.54 K
-2 680.16
-7 329.23
-75.71 K
-89.39 K
483.57
-163.9 K
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
12.14
14.68
12.93
18.26
15.43
12.65
54.42
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.01
0.02
0.01
0
0
0.09
0.12
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
0
-0.01
0.01
0.04
0.03
0.09
0.18
Long term debt to total equity ratio
0
-0.01
0.01
0.05
0.03
0.12
0.22
Per share metrics
Operating cash flow per share
—
-4.58
-2.92
-4.12
-775.13
1 009.69
-815.42
EBIT per share
—
—
—
—
—
—
—
EBITDA per share
—
—
—
—
—
—
—
Total debt per share
—
—
—
—
—
—
—
Cash per share
—
16.53
13.23
10.67
2 394.25
3 195.38
9 233.79
Net current asset value per share
—
16.79
13.44
10.87
2 463.85
3 266.74
9 722.97
Tangible book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
Working capital per share
—
15.65
12.4
10.27
2 304.12
3 008.48
8 975.44
Book value per share
—
4.52
7.88
5.26
1 610.69
2 155.74
5 926.7
新闻
Stifel重申Viridian Therapeutic股票评级,关注生物制品许可申请审查
Stifel reiterates Viridian Therapeutic stock rating on BLA review
Jefferies上调Viridian Therapeutic目标价,看好临床试验进展
Jefferies raises Viridian Therapeutic stock price target on trial progress
Evercore ISI基于数据信心重申Viridian Therapeutics股票评级
Evercore ISI reiterates Viridian Therapeutic stock rating on data conviction
Viridian Therapeutics, Inc. (VRDN) Reports Q4 Loss, Misses Revenue Estimates
Viridian TherapeuticsQ4每股收益及营收逊于预期
Viridian Therapeutics earnings missed by $0.10, revenue fell short of estimates
MiMedx (MDXG) Q4 Earnings and Revenues Beat Estimates
BB Biotech 2025财年业绩:利润飙升660%,但对2026年持谨慎态度
Truist重申Viridian Therapeutics股票评级,试验结果即将公布